Published in Antimicrob Agents Chemother on May 01, 1984
Molecular basis of bacterial outer membrane permeability. Microbiol Rev (1985) 17.75
Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol (1993) 6.24
Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob Agents Chemother (1993) 2.52
Antibiotic-supersusceptible mutants of Escherichia coli and Salmonella typhimurium. Antimicrob Agents Chemother (1993) 2.00
Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12. Antimicrob Agents Chemother (1988) 1.70
Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci U S A (2010) 1.54
Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility. Antimicrob Agents Chemother (1989) 1.29
Escherichia coli susceptible to glycopeptide antibiotics. Antimicrob Agents Chemother (1989) 1.05
Variability of cell surface hydrophobicity among Pasteurella multocida somatic serotype and Actinobacillus lignieresii strains. J Clin Microbiol (1987) 0.92
Differences in antimicrobial susceptibility of pigmented and unpigmented colonial variants of Mycobacterium avium. J Clin Microbiol (1989) 0.85
Susceptibility to hydrophobic molecules and phospholipid composition in Pasteurella multocida and Actinobacillus lignieresii. Antimicrob Agents Chemother (1988) 0.84
Characterization of the β-barrel assembly machine accessory lipoproteins from Borrelia burgdorferi. BMC Microbiol (2015) 0.76
Synergistic effect of imp/ostA and msbA in hydrophobic drug resistance of Helicobacter pylori. BMC Microbiol (2009) 0.75
Hybridization between Escherichia coli and Shigella. J Bacteriol (1957) 18.56
Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics. Antimicrob Agents Chemother (1977) 7.70
Outer membrane of Salmonella typhimurium. Transmembrane diffusion of some hydrophobic substances. Biochim Biophys Acta (1976) 7.44
Protein composition of the outer membrane of Salmonella typhimurium: effect of lipopolysaccharide mutations. J Bacteriol (1974) 7.07
Outer membrane of Salmonella typhimurium: chemical analysis and freeze-fracture studies with lipopolysaccharide mutants. J Bacteriol (1975) 6.51
The barrier function of the gram-negative envelope. Ann N Y Acad Sci (1974) 6.08
Alterations in the outer membrane of the cell envelope of heptose-deficient mutants of Escherichia coli. J Bacteriol (1974) 4.96
Pleiotropic transport mutants of Escherichia coli lack porin, a major outer membrane protein. Mol Gen Genet (1977) 4.15
Two mutations which affect the barrier function of the Escherichia coli K-12 outer membrane. J Bacteriol (1979) 2.77
Two transport systems for tetracycline in sensitive Escherichia coli: critical role for an initial rapid uptake system insensitive to energy inhibitors. Antimicrob Agents Chemother (1978) 2.68
Conjugation deficient E. coli K12 F- mutants with heptose-less lipopolysaccharide. Mol Gen Genet (1976) 2.22
Permeability of the outer membrane of bacteria. Angew Chem Int Ed Engl (1979) 1.78
Active uptake of tetracycline by membrane vesicles from susceptible Escherichia coli. Antimicrob Agents Chemother (1981) 1.66
Diffusion of tetracycline across the outer membrane of Escherichia coli K-12: involvement of protein Ia. Biochem Biophys Res Commun (1978) 1.55
[Antibiotic sensitivity in S- and R-forms of Salmonella minnesota]. Naturwissenschaften (1968) 1.45
Molecular organization of the outer membrane of Salmonella typhimurium. Eur J Biochem (1979) 1.41
Susceptible Escherichia coli cells can actively excrete tetracyclines. Antimicrob Agents Chemother (1983) 1.40
Tetracycline resistance determinants from groups A to D vary in their ability to confer decreased accumulation of tetracycline derivatives by Escherichia coli. J Gen Microbiol (1982) 1.40
Transport of tetracyclines through the bacterial cell membrane assayed by fluorescence: a study with susceptible and resistant strains of Staphylococcus aureus and Escherichia coli. Microbios (1978) 1.24
Characterization of the active transport of chlorotetracycline in staphylococcus aureus by a fluorescence technique. J Supramol Struct (1974) 1.22
Membrane phase transitions and the transport of chlortetracycline. Arch Biochem Biophys (1975) 1.02
Limitations of a fluorescence assay for studies on tetracycline transport into Escherichia coli. Antimicrob Agents Chemother (1983) 0.84
Outer membrane composition in Escherichia coli and the poor activity of hydrophobic antibiotics against enteric bacteria. J Antimicrob Chemother (1982) 0.83
Heterogeneity of antigenic-side-chain length in lipopolysaccharide from Escherichia coli 0111 and Salmonella typhimurium LT2. Eur J Biochem (1980) 8.02
Release of lipopolysaccharide by EDTA treatment of E. coli. Biochem Biophys Res Commun (1965) 7.38
Physical, chemical, and immunological properties of lipopolysaccharide released from Escherichia coli by ethylenediaminetetraacetate. J Biol Chem (1968) 7.13
The barrier function of the gram-negative envelope. Ann N Y Acad Sci (1974) 6.08
Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate. J Biol Chem (1968) 6.06
Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. J Biol Chem (1975) 4.80
Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet (2001) 4.70
Synthesis, utilization and degradation of lactose operon mRNA in Escherichia coli. J Mol Biol (1967) 3.13
Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis (2001) 2.97
Urban traffic and pollutant exposure related to respiratory outcomes and atopy in a large sample of children. Eur Respir J (2003) 2.79
Two mutations which affect the barrier function of the Escherichia coli K-12 outer membrane. J Bacteriol (1979) 2.77
Regulation of isoleucine-valine biosynthesis in an ilvDAC deletion strain of Escherichia coli K-12. Biochem Biophys Res Commun (1974) 2.35
An equilibrium between two fractions of lipopolysaccharide in Escherichia coli. Proc Natl Acad Sci U S A (1968) 2.33
Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J (2004) 2.18
Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen. J Bacteriol (1984) 2.12
Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen. J Immunol (1983) 1.90
Controlling EDTA treatment to produce permeable Escherichia coli with normal metabolic processes. Biochem Biophys Res Commun (1967) 1.85
Reliability of the Washington University Road Test. A performance-based assessment for drivers with dementia of the Alzheimer type. Arch Neurol (1997) 1.84
A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum. J Bacteriol (1982) 1.84
C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J Immunol (1986) 1.82
Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol (1986) 1.80
Association between polymorphisms in serine protease inhibitor, kazal type 5 and asthma phenotypes in a large German population sample. Clin Exp Allergy (2004) 1.80
Farnesyl transferase inhibitors block the farnesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubules. J Biol Chem (2000) 1.78
Release of lipopolysaccharide in Escherichia coli resistant to the permeability increase induced by ethylenediaminetetraacetate. J Biol Chem (1970) 1.72
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Analysis of variation in PF83, an erythrocytic merozoite vaccine candidate antigen of Plasmodium falciparum. Mol Biochem Parasitol (1991) 1.65
The transport of diaminopimelate and cystine in Escherichia coli. J Biol Chem (1965) 1.58
Effect of variations in lipopolysaccharide on the fluidity of the outer membrane of Escherichia coli. J Biol Chem (1977) 1.56
A case of euglycaemic diabetic ketoacidosis in pregnancy. Diabet Med (2001) 1.54
Glutathione S transferase deficiency and passive smoking increase childhood asthma. Thorax (2004) 1.49
Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J Immunol (1982) 1.45
Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide. Infect Immun (1984) 1.42
Mode of insertion of lipopolysaccharide into the outer membrane of escherichia coli. J Bacteriol (1976) 1.42
A procedure to overcome interferences caused by the adulterant "Klear" in the GC-MS analysis of 11-nor-delta9-THC-9-COOH. J Anal Toxicol (1997) 1.39
The rfaD gene codes for ADP-L-glycero-D-mannoheptose-6-epimerase. An enzyme required for lipopolysaccharide core biosynthesis. J Biol Chem (1983) 1.37
Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. J Clin Invest (1996) 1.36
Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae. Infect Immun (1983) 1.34
Cloning, expression, and characterization of the Escherichia coli K-12 rfaD gene. J Bacteriol (1990) 1.33
Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length. J Immunol (1984) 1.28
Release from Escherichia coli of a galactosyltransferase complex active in lipopolysaccharide synthesis. J Biol Chem (1970) 1.27
Identification of outer membrane proteins, including known lymphocyte mitogens, as the endotoxin protein of Escherichia coli 0111. J Immunol (1981) 1.27
Ras oncoprotein inhibitors: the discovery of potent, ras nucleotide exchange inhibitors and the structural determination of a drug-protein complex. Bioorg Med Chem (1997) 1.27
Lumbar paraspinal compartment syndrome. A case report with physiologic and anatomic studies. Spine (Phila Pa 1976) (1985) 1.27
A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4. J Immunol (1984) 1.26
Growth hormone release inhibiting hormone in acromegaly. Br Med J (1974) 1.24
The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet (1999) 1.19
A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet (1998) 1.18
Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clin Infect Dis (1999) 1.17
Nutritional parameters in children with cancer. J Am Diet Assoc (1983) 1.14
Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I. J Biol Chem (1997) 1.14
The crystal structure of ADP-L-glycero-D-mannoheptose 6-epimerase: catalysis with a twist. Structure (2000) 1.14
Management of cancer symptoms: pain, depression, and fatigue. Evid Rep Technol Assess (Summ) (2002) 1.14
Determinants of endotoxin levels in living environments of farmers' children and their peers from rural areas. Clin Exp Allergy (2004) 1.14
Effect of ethylenediaminetetraacetate upon the surface of Escherichia coli. J Bacteriol (1977) 1.12
Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. J Immunol (1983) 1.12
Recurrence of recipient Langerhans' cell histiocytosis following bilateral lung transplantation. Thorax (1998) 1.11
IgG subclass distribution of thyroid autoantibodies: a 'fingerprint' of an individual's response to thyroglobulin and thyroid microsomal antigen. Clin Endocrinol (Oxf) (1987) 1.11
HUBNET: Wide Area Network utilization of Local Area Network medical reference and communication resources. Proc Annu Symp Comput Appl Med Care (1994) 1.06
Case of self-poisoning with multiple antidepressant drugs. Lancet (1970) 1.06
Cloning and characterization of the Escherichia coli K-12 rfa-2 (rfaC) gene, a gene required for lipopolysaccharide inner core synthesis. J Bacteriol (1993) 1.05
Exposure to pets, and the association with hay fever, asthma, and atopic sensitization in rural children. Allergy (2005) 1.05
Kinematic effects of deafferentation and cerebellar ablation. Brain (1976) 1.05
A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE or atopic diseases. Allergy (2004) 1.04
Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography. Stroke (1986) 1.03
The farnesyl transferase inhibitor SCH 66336 induces a G(2) --> M or G(1) pause in sensitive human tumor cell lines. Exp Cell Res (2001) 1.02
Evidence for a gradient of exogenous and endogenous diaminopimelate in Escherichia coli. J Biol Chem (1965) 1.02
Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study. J Antimicrob Chemother (2000) 1.01
Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. J Clin Endocrinol Metab (2000) 0.99
Environmental cueing may effect performance on a road test for drivers with dementia of the Alzheimer type. Alzheimer Dis Assoc Disord (1997) 0.99
Domains involving nonrandom distribution of lipopolysaccharide in the outer membrane of Escherichia coli. Proc Natl Acad Sci U S A (1977) 0.98
New cysE-pyrE-linked rfa mutation in Escherichia coli K-12 that results in a heptoseless lipopolysaccharide. J Bacteriol (1985) 0.96
Distal posterior interosseous nerve syndrome. J Hand Surg Am (1985) 0.95
Spontaneous and induced metastasis of naturally occurring tumors in mice: analysis of cell shedding into the blood. J Natl Cancer Inst (1984) 0.95
Pulmonary haemorrhage complicating Wegener's granulomatosis and microscopic polyarteritis. Br Med J (Clin Res Ed) (1985) 0.95
Granulomatous cheilitis in Crohn's disease. Br Med J (1974) 0.95
Experimental analysis of factors affecting metastatic spread using naturally occurring tumours. Invasion Metastasis (1982) 0.95
Genetic analysis of Escherichia coli O111:B4, a strain of medical and biochemical interest. J Bacteriol (1977) 0.95
Growth hormone and insulin binding to human liver. J Clin Endocrinol Metab (1976) 0.93
The identification of markers segregating with resistance to Schistosoma mansoni infection in the snail Biomphalaria glabrata. Proc Natl Acad Sci U S A (1999) 0.92
C3b binding, but not its breakdown, is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae. J Immunol (1986) 0.91
Lung function of school children with low levels of alpha1-antitrypsin and tobacco smoke exposure. Eur Respir J (2002) 0.90
Interaction of Metals and Protons with Algae. 4. Ion Exchange vs Adsorption Models and a Reassessment of Scatchard Plots; Ion-Exchange Rates and Equilibria Compared with Calcium Alginate. Environ Sci Technol (1994) 0.89
Antibody-guided radiolocalisation of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphatase. Br J Radiol (1986) 0.88
Actinomycin resistance and actinomycin excretion in a mutant of Escherichia coli. J Bacteriol (1970) 0.88
The role of bone scanning in Paget's disease. Metab Bone Dis Relat Res (1981) 0.88
A comparison of bone scanning and radiology in the assessment of patients with symptomatic Paget's disease. Eur J Nucl Med (1980) 0.88
Village mothers on the West Bank learn about health. World Health Forum (1988) 0.87
Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophinreleasing hormone. Br Med J (1975) 0.87
Clinical and epidemiological characteristics of Eimeria infections in first-year grazing cattle. Vet Parasitol (2006) 0.86
Purification and properties of the Escherichia coli K-12 NAD-dependent nucleotide diphosphosugar epimerase, ADP-L-glycero-D-mannoheptose 6-epimerase. J Biol Chem (1994) 0.86
Tolerance to subchronic, high-dose ingestion of erythritol in human volunteers. Regul Toxicol Pharmacol (1996) 0.86
C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae. J Immunol (1987) 0.86
Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylation. Bioorg Med Chem (1997) 0.86
Detection of reverse transcriptase activity in association with the non-A, non-B hepatitis agent(s). Lancet (1984) 0.86
Why study pain? A qualitative analysis of medical and nursing faculty and students' knowledge of and attitudes to cancer pain management. J Palliat Med (2002) 0.86
A comparison of bone scanning and radiology in the evaluation of patients with metabolic bone disease. Clin Radiol (1980) 0.86